Drug Profile
Sulotroban
Alternative Names: BM 13177; SKF 95587Latest Information Update: 17 Feb 2006
Price :
$50
*
At a glance
- Originator Roche
- Developer GlaxoSmithKline; Roche
- Class
- Mechanism of Action Thromboxane A2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Myocardial infarction; Thrombosis